Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC
April 24, 2014 at 10:17 AM EDT
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) an oncology company focused on the development of innovative approaches to targeting and ...